Site updated at Wednesday, 22 June 2016

Living with Dementia

Alzheimer Treatment

India’s Piramal buys Bayer’s potential Alzheimer drug

Indian drugmaker Piramal Healthcare has agreed to buy a research and development portfolio from Bayer AG, the company said, in a deal that gives Piramal rights to florbetaben, a possible Alzheimer treatment.

Florbetaben, which is in the final stages of clinical trials, works by detecting symptoms in probable sufferers of Alzheimer’s, and is expected… India’s Piramal buys Bayer’s potential Alzheimer drug   


psychotic symptoms1 - amyloid beta 42 peptide1 - lewis and short1 - haloperidol2 - motor coordination1 - examination of handwriting1 - artery-clogging process1 - late-onset alzheimer's2 - dementia-related diseases1 - grandiosity1 - antioxidants1 - emotional symptoms1 - burden of dementia1 - astro-gliosis1 - neurofibrillary tangle1 - loss of neuronal connections1 - biomarkers of alzheimer's disease1 - islet amyloid polypeptide1 - behaviours redolent1 - progressive neurodegenerative disorder1 - socioeconomic boundaries1 - blood pressure6 - abnormal tau protein1 - frontal-lobe degeneration1 - amyvid2 - invisible disease1 - mri2 - alzheimers symptoms1 - dementia risk4 - delirium tremens1 -